Today’s top gainers include the company Amgen Inc. (NASDAQ:AMGN) which is in the industry Biotechnology, gaining 0.34% today. In the last week its performance is -0.14%, and 13.52% for the past quarter. Currently, Amgen Inc., AMGN has a target price of 189.94, so today’s gain of 0.34% is a significant step towards its target price. The GAP today is therefore -0.69%.
Amgen Inc. (NASDAQ:AMGN), has a market cap of 130146.71, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 82.00%.
At the current price of 173.02, it has a dividend yield of 2.32%, and its target price is 189.94. This is with a profit margin of 33.50%, and total debt/equity of 1.1. Amgen Inc. (NASDAQ:AMGN) has a P/E of 18.25, as well as a forward P/E of 13.88.
With a current EPS of 9.45, and a forecasted EPS growth for next year at 9.41%,Amgen Inc. (NASDAQ:AMGN) has had a EPS growth for the past five years at 13.60%. For the next five years EPS growth is projected to be 8.50%.
Performance for the year is 3.43%. Since its IPO date on 9/7/1984, the total performance to date is 7.66%.
Volume today for Amgen Inc. (NASDAQ:AMGN), is 1862999, while its average volume is 2894.43. Whilst the total gain today was 0.34%, it did have a day high of -1.97%.
Volatility for this week has been at 1.07%, and 1.42% for the month. The 52-week low for Amgen Inc., AMGN has been 35.49%, while the 52-week-high has reached -1.97%.
Looking at its return of investments, which is 12.50%, and its return on assets is 10.10%. Amgen Inc. (NASDAQ:AMGN) has an operating margin of 41.30%. With a sales growth of 5.90% quarter over quarter. Bearing in mind that Amgen Inc., AMGN is in the sector Healthcare, its long-term debt/equity is 0.93, and has a current ratio of 4 and 3.7 for quick ratio.
So what is the value of Amgen Inc.? Well its PEG is 2.15, and the P/S is 5.87, along with a P/B of 4.3. Meanwhile it has a p/cash of 3.71.